Sagramostim
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
617 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Leukemia | D007938 | — | C95 | 21 | 50 | 10 | 1 | 2 | 77 |
| Lymphoma | D008223 | — | C85.9 | 18 | 50 | 5 | 1 | 1 | 70 |
| Melanoma | D008545 | — | — | 22 | 41 | 7 | 1 | 5 | 68 |
| Neuroblastoma | D009447 | EFO_0000621 | — | 13 | 31 | 5 | 3 | 2 | 48 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 9 | 15 | 4 | 1 | — | 27 |
| Lymphoid leukemia | D007945 | — | C91 | 4 | 14 | 1 | 1 | — | 18 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | — | 3 | 8 | 2 | 1 | — | 12 |
| Covid-19 | D000086382 | — | — | 1 | 7 | 3 | 1 | — | 10 |
| Hepatitis b | D006509 | — | — | — | 2 | 1 | 1 | 1 | 5 |
| Sepsis | D018805 | HP_0100806 | A41.9 | 1 | 2 | 2 | 1 | — | 5 |
Show 11 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 22 | 29 | 5 | — | — | 48 |
| Prostatic neoplasms | D011471 | — | C61 | 15 | 32 | 3 | — | — | 45 |
| Multiple myeloma | D009101 | — | C90.0 | 13 | 26 | 3 | — | — | 38 |
| Plasma cell neoplasms | D054219 | — | — | 13 | 22 | 3 | — | — | 34 |
| Myeloid leukemia | D007951 | — | C92 | 8 | 21 | 5 | — | — | 33 |
| Myelodysplastic syndromes | D009190 | — | D46 | 13 | 20 | 1 | — | 1 | 32 |
| Preleukemia | D011289 | — | — | 12 | 17 | 1 | — | 1 | 28 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 6 | 19 | 3 | — | — | 26 |
| Carcinoma | D002277 | — | C80.0 | 12 | 14 | 1 | — | 1 | 25 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 13 | 7 | 2 | — | 4 | 23 |
Show 45 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | 28 | 35 | — | — | 2 | 55 |
| Lung neoplasms | D008175 | HP_0100526 | C34.90 | 10 | 16 | — | — | — | 23 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 10 | 14 | — | — | — | 22 |
| Colorectal neoplasms | D015179 | — | — | 10 | 15 | — | — | — | 19 |
| Syndrome | D013577 | — | — | 8 | 12 | — | — | 1 | 19 |
| Ovarian epithelial carcinoma | D000077216 | — | — | 7 | 10 | — | — | — | 16 |
| Non-small-cell lung carcinoma | D002289 | — | — | 6 | 8 | — | — | — | 12 |
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 3 | 10 | — | — | — | 12 |
| Myeloproliferative disorders | D009196 | — | D47.1 | 2 | 9 | — | — | 1 | 11 |
| Fallopian tube neoplasms | D005185 | — | — | 5 | 6 | — | — | — | 10 |
Show 127 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pancytopenia | D010198 | HP_0001876 | D61.81 | 4 | — | — | — | 3 | 7 |
| Leukopenia | D007970 | EFO_0004233 | D72.819 | 3 | — | — | — | 1 | 4 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | 3 | — | — | — | — | 3 |
| Kaposi sarcoma | D012514 | — | C46 | 2 | — | — | — | — | 2 |
| Ewing sarcoma | D012512 | EFO_0000173 | — | 2 | — | — | — | — | 2 |
| Diffuse intrinsic pontine glioma | D000080443 | — | — | 2 | — | — | — | — | 2 |
| Virus diseases | D014777 | — | B34 | 2 | — | — | — | — | 2 |
| Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | 1 | — | — | — | 1 | 2 |
| Plasma cell leukemia | D007952 | — | C90.1 | 1 | — | — | — | — | 1 |
| Basal cell carcinoma | D002280 | — | — | 1 | — | — | — | — | 1 |
Show 36 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Bone marrow failure disorders | D000080983 | — | — | — | — | — | — | 1 | 1 |
| Peritonitis | D010538 | EFO_0008588 | K65 | — | — | — | — | 1 | 1 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | — | — | — | 1 | 1 |
| Graft rejection | D006084 | — | — | — | — | — | — | 1 | 1 |
| Diabetic foot | D017719 | EFO_1001459 | — | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | — |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use